Alzheimer's is slowed by cholesterol-lowering drugs. In a three-year study of 300 Alzheimer's patients, the disease progressed more slowly (loss of 1.5 points in a 30-point mini mental status exam, or MMSE) in those who took a cholesterol-lowering drug than it did in those not taking the medication (loss of 2.5 points in MMSE).

Recent Studies Show: High cholesterol levels increase the deposition of proteins that can impair brain function.

Want to Keep Reading?

Continue reading with a Health Confidential membership.

Sign up now Already have an account? Sign in